insights_auto
Bakit tumaas ang 3692 8.32%?
Tingnan ang Higit pang Detalyechevron_right
3692:HKG
Hansoh Pharmaceutical Group Company Ltd
HK$34.38
arrow_upward
+8.32%(+2.64) 1D
Okt 20, 4:08:18 PM GMT+8 · HKD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 3692...
Buksan
HK$32.60
Mataas
HK$34.78
Mababa
HK$32.46
Mkt. cap
208.49B
Avg. na dami
8.86M
Dami
35.43M
Dividend
1.41%
Bawat tatlong buwang dividend
HK$0.12
Petsa ng ex-dividend
Set 22, 2026
P/E ratio
26.54
Mataas nang 52-wk
HK$44.22
Mababa nang 52-wk
HK$28.06
EPS
HK$1.30
Bilang ng mga empleyado
10K
Buksan
HK$32.60
Mataas
HK$34.78
Mababa
HK$32.46
Mkt. cap
208.49B
Avg. na dami
8.86M
Dami
35.43M
Dividend
1.41%
Bawat tatlong buwang dividend
HK$0.12
Petsa ng ex-dividend
Set 22, 2026
P/E ratio
26.54
Mataas nang 52-wk
HK$44.22
Mababa nang 52-wk
HK$28.06
EPS
HK$1.30
Bilang ng mga empleyado
10K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
1 oras ang nakalipas
Hansoh Pharma Stock Draws HKD 47.73 Target From 24 Analysts
Newsquawk
·
17 oras ang nakalipas
PRE-MARKET CHINESE STOCKS NEWS: Hansoh Pharma (3692 HK) struck an ADC licensing deal with Roche worth up to over USD 15bln in milestones; CSRC approved 18 actively managed ETFs to support the stock market
Yahoo Finance
·
1 araw ang nakalipas
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion
Yahoo Finance
·
1 araw ang nakalipas
Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness study
Profile
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Tungkol sa Hansoh Pharmaceutical Group Company Ltd